Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones

Journal of Cataract and Refractive Surgery

Volumn 35, Issue 3, 2009, Pages 475-479

  Hori, Yuichi ^a   Nakazawa, Toru ^a   Maeda, Naoyuki ^a   Sakamoto, Masako ^a   Yokokura, Syunji ^a   Kubota, Akira ^a   Inoue, Tomoyuki ^a   Nishida, Kohji ^a   Tano, Yasuo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM; BACTERIUM CULTURE; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONJUNCTIVA; CONTROLLED STUDY; CORYNEBACTERIUM; DISEASE PREDISPOSITION; DRUG EFFICACY; EYE SURGERY; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS AUREUS; SURGICAL PATIENT; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BACTERIA; CONJUNCTIVA; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OFLOXACIN; PREOPERATIVE CARE; QUINOLINES;

EID: 61549091811     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2008.11.049     Document Type: Article

References (26)

1. Liesegang T.J. Use of antimicrobials to prevent postoperative infection in patients with cataracts. Curr Opin Ophthalmol 12 (2001) 68-74
2. Miño de Kaspar H., Chang R.T., Shriver E.M., Singh K., Egbert P.R., Blumenkranz M.S., and Ta C.N. Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery; a prospective randomized study. Ophthalmology 111 (2004) 1352-1355
3. O'Brien T.P., Arshinoff S.A., and Mah F.S. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg 33 (2007) 1790-1800
4. Miño de Kaspar H., Kreutzer T.C., Aguirre-Romo I., Ta C.N., Dudichum J., Bayrhof M., Klauss V., and Kampik A. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol 145 (2008) 136-142
5. Alexandrakis G., Alfonso E.C., and Miller D. Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology 107 (2000) 1497-1502
6. Miller D., Flynn P.M., Scott I.U., Alfonso E.C., and Flynn Jr. H.F. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 124 (2006) 479-483
7. Miño de Kaspar H., Shriver E.M., Nguyen E.V., Egbert P.R., Singh K., Blumenkranz M.S., and Ta C.N. Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefes Arch Clin Exp Ophthalmol 241 (2003) 730-733
8. Marangon F.B., Miller D., Muallem M.S., Romano A.C., and Alfonson E.C. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol 137 (2004) 453-458
9. Hori Y., Maeda N., Sakamoto M., Koh S., Inoue T., and Tano Y. Bacteriologic profile of the conjunctiva in the patients with dry eye. Am J Ophthalmol 146 (2008) 729-734
10. Kowalski R.P., Yates K.A., Romanowski E.G., Karenchak L.M., Mah F.S., and Gordon Y.J. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology 112 (2005) 1987-1991
11. Kato T., and Hayasaka S. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients. Jpn J Ophthalmol 42 (1998) 461-465
12. Watanabe K., Numata-Watanabe K., and Hayasaka S. Methicillin-resistant staphylococci and ofloxacin-resistant bacteria from clinically healthy conjunctivas. Ophthalmic Res 33 (2001) 136-139
13. Fukuda M., Ohashi H., Matsumoto C., Mishima S., and Shimomura Y. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea 21 suppl 2 (2002) S86-S89
14. Iihara H., Suzuki T., Kawamura Y., Ohkusu K., Inoue Y., Zhang W., Shah M.M., Katagiri Y., Ohashi Y., and Ezaki T. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. Diagn Microbiol Infect Dis 56 (2006) 297-303
15. Moshirfar M., Mirzaian G., Feiz V., and Kang P.C. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refract Surg 32 (2006) 515-518
16. Jhanji V., Sharma N., Satpathy G., and Titiyal J. Fourth-generation fluoroquinolone-resistant bacterial keratitis. J Cataract Refract Surg 33 (2007) 1488-1489
17. Hollander D.A., Stewart J.M., Seiff S.R., and Stewart J.M. Late-onset Corynebacterium endophthalmitis following laser posterior capsulotomy. Ophthalmic Surg Lasers Imaging 35 (2004) 159-161
18. Hollander D.A., Vagefi M.R., Seiff S.R., Poothullil A.M., and Jeng B.H. Bacterial endophthalmitis after resident-performed cataract surgery. Am J Ophthalmol 141 (2006) 949-951
19. Ferrer C., Ruiz-Moreno J.M., Rodríguez A., Montero J., and Alió J.L. Postoperative corynebacterium macginleyi endophthalmitis. J Cataract Refract Surg 30 (2004) 2441-2444
20. Kowalski R.P., Dhaliwal D.K., Karenchak L.M., Romanowski E.G., Mah F.S., Ritterband D.C., and Gordon Y.J. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136 (2003) 500-505
21. Thibodeaux B.A., Dajcs J.J., Caballero A.R., Marquart M.E., Girgis D.O., and O'Callaghan R.J. Quantitative comparison of fluoroquinolone therapies of experimental Gram-negative bacterial keratitis. Curr Eye Res 28 (2004) 337-342
22. Stroman D.W., Dajcs J.J., Cupp G.A., and Schlech B.A. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%; a new topical fluoroquinolone. Surv Ophthalmol 50 suppl (2005) S16-S31
23. Miño de Kaspar H., Koss M.J., He L., Blumenkranz M.S., and Ta C.N. Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol 139 (2005) 730-733
24. Ta C.N., Singh K., Egbert P.R., and Mino de Kaspar H. Prospective comparative evaluation of povidone-iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for ophthalmic surgery. J Cataract Refract Surg 34 (2008) 171-172
25. Ciulla T.A., Starr M.B., and Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology 109 (2002) 13-24
26. Barry P., Seal D.V., Gettinby G., Peterson M., and Revie C.W. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study. the ESCRS Endophthalmitis Study Group J Cataract Refract Surg 32 (2006) 407-410